Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL
Also known as: Acute myeloid leukemia with KMT2A rearrangement (morphologic abnormality) / Acute myeloid leukemia with 11q23-abnormality / Acute myeloid leukemia with 11q23-abnormality not having achieved remission / Acute myeloid leukemia with 11q23 abnormality (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|